Showing results 1 to 1 of 1
Issue Date | Title | Journal Title |
---|---|---|
2023 | Trastuzumab Deruxtecan in Anti-Human Epidermal Growth Factor Receptor 2 Treatment-Naive Patients With Human Epidermal Growth Factor Receptor 2-Low Gastric or Gastroesophageal Junction Adenocarcinoma: Exploratory Cohort Results in a Phase II Trial | JOURNAL OF CLINICAL ONCOLOGY |